Loss and Grief Among Bereaved Family Members During COVID-19 in Brazil: A Grounded Theory Analysis.

Publication date: Jun 17, 2025

The COVID-19 pandemic has resulted in countless losses around the world, profoundly affecting the lives of many people, especially those who faced the death of family members, bringing several negative repercussions to these families and constraining the experience of grief. This study aimed to understand the experience of loss and grief among bereaved individuals who lost family members during the COVID-19 pandemic. This qualitative study was guided by Charmaz’s constructivist grounded theory as a methodological framework. The study adhered to the Criteria for REporting Qualitative research (COREQ) checklist. Data collection took place between May and November 2023 through telephone interviews that were audio-recorded and later transcribed in full. The purposive sample consisted of 21 bereaved family members who had lost their loved ones during the COVID-19 pandemic. Participants were mainly female (n = 16) with a mean age of 55. 5 (SD = 16. 2). The loss of their family members occurred 12 to 24 months before data collection. The following central phenomenon was identified through the analytical process: “Family experience of loss and grief: between the unspoken goodbye and post-loss adjustment”. This was anchored in the following three categories: (1) Anguish and fear of the unknown; (2) Death by COVID-19-communication of death and lack of goodbyes; and (3) (Re)construction of meaning-support networks and the grieving process. Our findings recommend that policymakers allocate additional resources to grief support services to better prepare for future pandemic events. Furthermore, it is necessary to invest in the implementation of relevant training programs for healthcare professionals, with a family centered approach.

Open Access PDF

Concepts Keywords
Brazil bereavement
Grief Brazil
Healthcare COVID-19
Interviews family
Months grief
grounded theory
loss

Semantics

Type Source Name
disease MESH COVID-19
disease MESH death
disease IDO process
drug DRUGBANK Tropicamide
drug DRUGBANK Coenzyme M
disease MESH confusion
disease MESH apathy
drug DRUGBANK Troleandomycin
disease MESH loneliness
disease MESH psychological distress
disease MESH uncertainty
disease MESH complications
disease IDO country
disease MESH Influenza
disease IDO history
drug DRUGBANK Ethanol
disease MESH infection
disease MESH COPD
drug DRUGBANK Etoperidone
drug DRUGBANK Ivermectin
drug DRUGBANK Oxygen
disease MESH shock
disease MESH scars
disease MESH numbness
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Cysteamine
disease MESH separation anxiety
disease MESH Prolonged Grief Disorder
disease MESH chronic conditions
disease MESH depression
disease MESH psychological well being
disease IDO intervention
drug DRUGBANK Deoxy-2-Fluoro-B-D-Cellotrioside
drug DRUGBANK Isoxaflutole
disease MESH mental disorders
disease MESH causes
disease MESH Affective Disorders
disease MESH Morbidity
disease MESH Emergency
disease MESH Psychological Trauma
disease IDO symptom

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *